-
Je něco špatně v tomto záznamu ?
Long-term adaptation to high doses of morphine causes desensitization of mu-OR- and delta-OR-stimulated G-protein response in forebrain cortex but does not decrease the amount of G-protein alpha subunits
L. Bourova, M. Vosahlikova, D. Kagan, K. Dlouha, J. Novotny, P. Svoboda,
Jazyk angličtina Země Polsko
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
20671607
Knihovny.cz E-zdroje
- MeSH
- abstinenční syndrom patofyziologie MeSH
- baklofen farmakologie MeSH
- buněčná membrána účinky léků enzymologie MeSH
- časové faktory MeSH
- chování zvířat účinky léků MeSH
- enkefalin, Ala(2)-MePhe(4)-Gly(5)- farmakologie MeSH
- fyziologická adaptace účinky léků MeSH
- guanosin 5'-O-(3-thiotrifosfát) metabolismus MeSH
- guanosindifosfát metabolismus MeSH
- krysa rodu rattus MeSH
- morfin aplikace a dávkování farmakologie MeSH
- mozková kůra účinky léků metabolismus MeSH
- potkani Wistar MeSH
- proteiny vázající GTP - alfa-podjednotky metabolismus MeSH
- receptory opiátové delta agonisté metabolismus MeSH
- receptory opiátové mu agonisté metabolismus MeSH
- tolerance léku MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: The functional activity of trimeric guanine-nucleotide-binding proteins (G-proteins) represents an essential step in linking and regulation of the opioid receptor (mu-, delta- and kappa-OR)-initiated signaling pathways. Theoretical basis and/or molecular mechanism(s) of opioid tolerance and addiction proceeding in the central nervous system were not studied in the forebrain cortex of mammals with respect to quantitative analysis of opioid-stimulated trimeric G-protein activity. MATERIAL/METHODS: G-protein activity was measured in PercollR-purified plasma membranes (PM) isolated from the frontal brain cortex of control and morphine-treated rats by both high-affinity [32P]GTPase and [35S]GTPgammaS binding assays. Exposition to morphine was performed by intra-muscular application of this drug. Control animals were injected with sterile PBS. RESULTS: Both mu-OR (DAMGO)- and delta-OR (DADLE)-responses were clearly desensitized in PM isolated from morphine-treated rats; kappa-OR (U-69593)- and baclofen (GABAB-R)-stimulated [35S]GTPgammaS binding was unchanged, indicating the specificity of the morphine effect. Under such conditions, the amount of G-protein alpha subunits was unchanged. The order of efficacy DADLE>DAMGO>U-69593 was the same in control and morphine-treated PM. Behavioral tests indicated that morphine-treated animals were fully drug-dependent and developed tolerance to subsequent drug addition. CONCLUSIONS: Prolonged exposure of rats to high doses of morphine results in decrease of the over-all output of OR-stimulated G-protein activity in the forebrain cortex but does not decrease the amount of these regulatory proteins. These data support the view that the mechanism of the long-term adaptation to high doses of morphine is primarily based on desensitization of OR-response preferentially oriented to mu-OR and delta-OR.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12026204
- 003
- CZ-PrNML
- 005
- 20121210093008.0
- 007
- ta
- 008
- 120817s2010 pl f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)20671607
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Bourova, Lenka $u Laboratory of Membrane Receptors, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. bourova@biomed.cas.cz
- 245 10
- $a Long-term adaptation to high doses of morphine causes desensitization of mu-OR- and delta-OR-stimulated G-protein response in forebrain cortex but does not decrease the amount of G-protein alpha subunits / $c L. Bourova, M. Vosahlikova, D. Kagan, K. Dlouha, J. Novotny, P. Svoboda,
- 520 9_
- $a BACKGROUND: The functional activity of trimeric guanine-nucleotide-binding proteins (G-proteins) represents an essential step in linking and regulation of the opioid receptor (mu-, delta- and kappa-OR)-initiated signaling pathways. Theoretical basis and/or molecular mechanism(s) of opioid tolerance and addiction proceeding in the central nervous system were not studied in the forebrain cortex of mammals with respect to quantitative analysis of opioid-stimulated trimeric G-protein activity. MATERIAL/METHODS: G-protein activity was measured in PercollR-purified plasma membranes (PM) isolated from the frontal brain cortex of control and morphine-treated rats by both high-affinity [32P]GTPase and [35S]GTPgammaS binding assays. Exposition to morphine was performed by intra-muscular application of this drug. Control animals were injected with sterile PBS. RESULTS: Both mu-OR (DAMGO)- and delta-OR (DADLE)-responses were clearly desensitized in PM isolated from morphine-treated rats; kappa-OR (U-69593)- and baclofen (GABAB-R)-stimulated [35S]GTPgammaS binding was unchanged, indicating the specificity of the morphine effect. Under such conditions, the amount of G-protein alpha subunits was unchanged. The order of efficacy DADLE>DAMGO>U-69593 was the same in control and morphine-treated PM. Behavioral tests indicated that morphine-treated animals were fully drug-dependent and developed tolerance to subsequent drug addition. CONCLUSIONS: Prolonged exposure of rats to high doses of morphine results in decrease of the over-all output of OR-stimulated G-protein activity in the forebrain cortex but does not decrease the amount of these regulatory proteins. These data support the view that the mechanism of the long-term adaptation to high doses of morphine is primarily based on desensitization of OR-response preferentially oriented to mu-OR and delta-OR.
- 650 _2
- $a fyziologická adaptace $x účinky léků $7 D000222
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a baklofen $x farmakologie $7 D001418
- 650 _2
- $a chování zvířat $x účinky léků $7 D001522
- 650 _2
- $a buněčná membrána $x účinky léků $x enzymologie $7 D002462
- 650 _2
- $a mozková kůra $x účinky léků $x metabolismus $7 D002540
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a tolerance léku $7 D004361
- 650 _2
- $a enkefalin, Ala(2)-MePhe(4)-Gly(5)- $x farmakologie $7 D020875
- 650 _2
- $a proteiny vázající GTP - alfa-podjednotky $x metabolismus $7 D044385
- 650 _2
- $a guanosin 5'-O-(3-thiotrifosfát) $x metabolismus $7 D016244
- 650 _2
- $a guanosindifosfát $x metabolismus $7 D006153
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a morfin $x aplikace a dávkování $x farmakologie $7 D009020
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a receptory opiátové delta $x agonisté $x metabolismus $7 D017465
- 650 _2
- $a receptory opiátové mu $x agonisté $x metabolismus $7 D017450
- 650 _2
- $a abstinenční syndrom $x patofyziologie $7 D013375
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vosahlikova, Miroslava
- 700 1_
- $a Kagan, Dmytro
- 700 1_
- $a Dlouha, Katerina
- 700 1_
- $a Novotny, Jiri
- 700 1_
- $a Svoboda, Petr
- 773 0_
- $w MED00003251 $t Medical science monitor : international medical journal of experimental and clinical research $x 1643-3750 $g Roč. 16, č. 8 (2010), s. BR260-70
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20671607 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121210093044 $b ABA008
- 999 __
- $a ok $b bmc $g 948246 $s 783550
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 16 $c 8 $d BR260-70 $i 1643-3750 $m Medical Science Monitor $n Med Sci Monit $x MED00003251
- LZP __
- $a Pubmed-20120817/10/04